Inovio, AstraZeneca terminate cancer vaccine partnership
November 02, 2021 at 11:36 AM EDT
Plymouth Meeting-based Inovio had the potential to earn up to $700 million through the original collaboration entered into six years ago.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|